Globe Life (GL) EVP Rebecca Zorn Sells 2,000 Shares

Rebecca Zorn Sells Shares of Globe Life Stock

Rebecca Zorn, executive vice president and chief talent officer at Globe Life Inc. (NYSE: GL), disposed of 2,000 shares of company stock on June 18, 2026. Executive stock sales happen for many personal financial reasons and do not point to any specific outlook from company management. Leaders often adjust their personal portfolios or manage equity grants through scheduled transactions.

Busy Insider Activity at Globe Life

This transaction joins a flurry of insider trading at the insurance provider over the summer. Earlier in the month, Co-Chairman and CEO Frank Svoboda executed multiple transactions, including buying and selling blocks of 10,000 shares on June 11 and June 12, 2026. Later in the month, EVP and Chief Administrative Officer Dolores Skarjune picked up 1,850 shares at $103.23 on June 30, 2026, before parting with an equal number of shares at $179.18 on the exact same day. These back-to-back moves by senior executives illustrate active equity management within the leadership team.

Globe Life Stock Valuation and Trading Range

Shares of Globe Life trade near $172.05, sitting comfortably inside their 52-week boundaries of $127.85 and $191.55. The company carries a price-to-earnings ratio of 11.45 and a forward P/E ratio of 10.42. These figures place the valuation in line with standard industry metrics for established financial services firms.

Recent Earnings and Financial Health

Globe Life reported solid fundamental metrics with an EPS of $15.04 and total revenue reaching $6.19 billion alongside a revenue growth rate of 0.08%. The firm generated a net margin of 19.58% and a return on equity of 20.94%. The next quarterly financial update is slated for October 21, 2026.

Dividend Profile for Shareholders

Income-focused participants track the company's annual dividend rate of $1.32 per share, which provides a dividend yield of 0.76%. The payout ratio sits at a conservative 7.98%, leaving ample room for retained earnings.

Wall Street Analyst Outlook

Major financial institutions keep a close eye on the insurer's path. On October 15, 2026, JP Morgan maintained an overweight rating while adjusting its price target to $195.00 from $193.00. Wells Fargo kept an overweight rating on October 12, 2026, with a target of $191.00, while Morgan Stanley maintained an overweight rating on October 5, 2026, setting its target at $197.00. Earlier, Keefe, Bruyette & Woods, TD Cowen, Piper Sandler, and Evercore ISI Group reviewed the firm. Across eleven analyst opinions, the stock holds a consensus target mean price of $193.91, with estimates ranging from a low of $166.00 to a high of $225.00.

Company Background in Life and Supplemental Health

Headquartered in McKinney, Texas, Globe Life provides life and supplemental health insurance products primarily geared toward lower-middle and middle-income families across the United States. The organization operates through specialized segments offering whole life, term life, Medicare supplement plans, and various health products through direct channels and independent agents.

What to Watch Next for Globe Life

Investors will look toward the upcoming October 21 earnings report for fresh updates on revenue trends and policy sales. Monitoring subsequent Form 4 filings will also show whether other executives continue adjusting their equity stakes as the year progresses.